Cooper Ashley, Robinson Samantha J, Pickard Chris, Jackson Claire L, Friedmann Peter S, Healy Eugene
Dermatopharmacology Unit, University of Southampton, Southampton, United Kingdom.
J Immunol. 2005 Oct 1;175(7):4806-13. doi: 10.4049/jimmunol.175.7.4806.
Studies in mice indicate that alpha-melanocyte-stimulating hormone (alphaMSH) is immunosuppressive, but it is not known whether alphaMSH suppresses human immune responses to exogenous Ags. Human PBMCs, including monocytes, express the melanocortin 1 receptor (MC1R), and it is thought that the ability of alphaMSH to alter monocyte-costimulatory molecule expression and IL-10 release is mediated by this receptor. However, the MC1R gene is polymorphic, and certain MC1R variants compromise receptor signaling via cAMP, resulting in red hair and fair skin. Here, we have investigated whether alphaMSH can suppress Ag-induced lymphocyte proliferation in humans and whether these effects are dependent on MC1R genotype. alphaMSH suppressed streptokinase-streptodornase-induced lymphocyte proliferation, with maximal inhibition at 10(-13)-10(-11) M alphaMSH. Anti-IL-10 Abs failed to prevent suppression by alphaMSH, indicating that it was not due to MC1R-mediated IL-10 release by monocytes. Despite variability in the degree of suppression between subjects, similar degrees of alphaMSH-induced immunosuppression were seen in individuals with wild-type, heterozygous variant, and homozygous/compound heterozygous variant MC1R alleles. RT-PCR of streptokinase-streptodornase-stimulated PBMCs for all five melanocortin receptors demonstrated MC1R expression by monocytes/macrophages, MC1R and MC3R expression by B lymphocytes, but no melanocortin receptor expression by T lymphocytes. In addition, alphaMSH did not significantly inhibit anti-CD3 Ab-induced lymphocyte proliferation, whereas alphaMSH and related analogs (SHU9119 and MTII) inhibited Ag-induced lymphocyte proliferation in monocyte-depleted and B lymphocyte-depleted assays. These findings demonstrate that alphaMSH, acting probably via MC1R on monocytes and B lymphocytes, and possibly also via MC3R on B lymphocytes, has immunosuppressive effects in humans but that suppression of Ag-induced lymphocyte proliferation by alphaMSH is independent of MC1R gene status.
对小鼠的研究表明,α-黑素细胞刺激素(αMSH)具有免疫抑制作用,但尚不清楚αMSH是否会抑制人类对外源性抗原的免疫反应。包括单核细胞在内的人类外周血单个核细胞(PBMC)表达黑素皮质素1受体(MC1R),人们认为αMSH改变单核细胞共刺激分子表达和白细胞介素-10(IL-10)释放的能力是由该受体介导的。然而,MC1R基因具有多态性,某些MC1R变体通过环磷酸腺苷(cAMP)损害受体信号传导,导致红发和白皙皮肤。在此,我们研究了αMSH是否能抑制人类抗原诱导的淋巴细胞增殖,以及这些效应是否依赖于MC1R基因型。αMSH抑制链激酶-链道酶诱导的淋巴细胞增殖,在αMSH浓度为10^(-13)-10^(-11) M时抑制作用最大。抗IL-10抗体未能阻止αMSH的抑制作用,表明这不是由于单核细胞通过MC1R介导释放IL-10所致。尽管不同个体之间抑制程度存在差异,但在具有野生型、杂合变体和纯合/复合杂合变体MC1R等位基因的个体中,αMSH诱导的免疫抑制程度相似。对链激酶-链道酶刺激的PBMC进行逆转录聚合酶链反应(RT-PCR)检测所有五种黑素皮质素受体,结果显示单核细胞/巨噬细胞表达MC1R,B淋巴细胞表达MC1R和MC3R,但T淋巴细胞不表达黑素皮质素受体。此外,αMSH并未显著抑制抗CD3抗体诱导淋巴细胞增殖,而在去除单核细胞和B淋巴细胞的试验中,αMSH及相关类似物(SHU9119和MTII)抑制抗原诱导的淋巴细胞增殖。这些发现表明,αMSH可能通过作用于单核细胞和B淋巴细胞上的MC1R,也可能通过作用于B淋巴细胞上的MC3R发挥免疫抑制作用,但αMSH对抗原诱导的淋巴细胞增殖的抑制作用与MC1R基因状态无关。